글로벌 심혈관 디지털 솔루션 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

심혈관 디지털 솔루션 시장 분석

심혈관 디지털 솔루션 시장은 심혈관 질환의 유병률 증가와 기술 발전에 힘입어 빠르게 확장되고 있습니다. AI 기반 영상, 웨어러블 기기 , 클라우드 기반 건강 정보와 같은 혁신은 진단 정확도를 높이고 실시간 원격 모니터링을 가능하게 함으로써 심혈관 치료에 혁명을 일으키고 있습니다. 예를 들어, Philips의 새로운 심장 초음파 플랫폼과 iRhythm Technologies의 AI 기반 심장 모니터링 솔루션은 환자 치료의 새로운 표준을 설정하고 있습니다. COVID-19 팬데믹으로 인해 촉진된 원격 진료의 빠른 도입은 심혈관 건강의 재택 관리를 지원하는 디지털 솔루션에 대한 수요를 더욱 높이고 있습니다. AI, 머신 러닝, 로봇 공학의 지속적인 발전으로 시장은 환자 결과를 개선하고 의료 제공을 간소화하기 위해 최첨단 기술을 계속 통합함에 따라 상당한 성장을 이룰 준비가 되었습니다.

심혈관 디지털 솔루션 시장 규모

글로벌 심혈관 디지털 솔루션 시장 규모는 2023년에 1,078억 9,000만 달러로 평가되었으며, 2031년까지 1,576억 7,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 5.57%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

심혈관 디지털 솔루션 시장 동향

“ 통합 디지털 플랫폼의 부상”

글로벌 심혈관 디지털 솔루션 시장은 기술의 발전과 원격 환자 모니터링에 대한 수요 증가에 힘입어 빠르게 확장되고 있습니다. 주목할 만한 추세 중 하나는 웨어러블 기기와 고급 분석을 결합하여 실시간으로 심혈관 건강을 모니터링하는 통합 디지털 플랫폼의 부상입니다. 예를 들어, ECG 및 심박수 모니터링 기능이 있는 스마트워치는  점점 더 인기를 얻고 있으며, 환자와 의료 서비스 제공자에게 지속적이고 실행 가능한 데이터를 제공합니다. 이러한 플랫폼은 인공 지능을 활용하여 데이터를 분석하고 잠재적인 심혈관 사건이 발생하기 전에 예측합니다. 이러한 추세는 조기 발견과 개인화된 치료를 향상시킬 뿐만 아니라 심혈관 상태의 사전 관리를 지원합니다. 기술이 계속 발전함에 따라 심혈관 치료에 디지털 솔루션을 통합하는 것이 증가하여 보다 포괄적이고 효율적인 관리 도구를 제공하고 시장에서 전반적인 환자 결과를 개선할 것으로 예상됩니다.

보고 범위 및 심혈관 디지털 솔루션 시장 세분화         

Cardiovascular Digital Solutions Market Definition

Cardiovascular digital solutions refer to a range of advanced technologies and tools designed to enhance the diagnosis, monitoring, and management of cardiovascular diseases. These solutions leverage digital platforms, such as AI-powered imaging systems, wearable devices, and cloud-based health informatics, to provide real-time data and insights into heart health. They aim to improve the accuracy of diagnoses, facilitate remote monitoring, and enable personalized treatment plans, thereby enhancing overall cardiovascular care and patient outcomes.

Cardiovascular Digital Solutions Market Dynamics

Drivers

• Increasing Cases of Cardiovascular Diseases

The global surge in cardiovascular diseases, which continue to be the leading cause of death worldwide, serves as a critical driver for the cardiovascular digital solutions market. The World Health Organization reports that cardiovascular diseases account for about 32% of all global deaths, translating to approximately 17.9 million fatalities each year. Such staggering statistic underscores the urgent need for advanced diagnostic and monitoring technologies to manage and prevent these life-threatening conditions effectively. As the prevalence of cardiovascular diseases continues to rise, the demand for innovative digital solutions that offer real-time monitoring, early detection, and personalized treatment options becomes increasingly vital, driving significant growth in the market.

• Rising Geriatric Population

The global aging population is significantly driving the demand for cardiovascular digital solutions, as older adults are more prone to heart-related conditions. According to the WHO, the number of people aged 60 and over is expected to reach nearly 2.1 billion by 2050, up from 1 billion in 2020. Geriatric demographic shift increases the prevalence of cardiovascular diseases among the elderly, prompting a greater need for digital solutions that address their specific health needs. For instance, remote monitoring systems and telehealth services are becoming essential for managing chronic conditions such as hypertension and heart disease in older adults. These technologies enable continuous monitoring of vital signs, timely interventions, and easier access to healthcare services, making them crucial for improving the health outcomes and quality of life for the aging population. Consequently driving the market growth.

Opportunities

• Growing Personalized Medicine and Precision Health Solutions

The rise of personalized medicine and precision health presents a significant opportunity in the cardiovascular digital solutions market. By integrating genetic, lifestyle, and health data, digital solutions can create individualized treatment plans that enhance patient outcomes and optimize care. For instance, platforms such as 23andMe's Health + Ancestry Service enable the assessment of genetic risk factors for cardiovascular diseases, facilitating tailored preventative strategies. Similarly, IBM Watson for Oncology leverages genetic and clinical data to offer personalized treatment recommendations. Such advancements underscore the potential for digital solutions to move beyond generic treatments, addressing individual patient needs and improving adherence. The shift towards more customized care not only promises better health outcomes but also fuels market growth by expanding the range and effectiveness of cardiovascular interventions.

• Rising Developments among Smart Implants and Advanced Medical Devices

The development of smart implants and advanced medical devices represents a promising opportunity in the cardiovascular digital solutions market. These innovations include devices such as the CardioMEMS HF System, which is a smart implantable sensor designed to monitor heart failure patient’s pulmonary artery pressure in real-time. By continuously providing data on patients cardiovascular health, smart implants facilitates early detection of worsening conditions and enable timely medical interventions. For instance, the Micra Transcatheter Pacemaker, a small, leadless pacemaker, continuously monitors heart rhythms and adjusts pacing in real-time, improving patient outcomes with minimal invasiveness. The ability of these devices to deliver ongoing, actionable data allows for proactive management of cardiovascular conditions, reduces hospitalizations, and enhances personalized care. As technology advances and these devices become more sophisticated, they present significant growth opportunities for the cardiovascular digital solutions market.

Restraints/Challenges

• Rising Concerns Regarding Data Security and Privacy

Data privacy and security concerns are critical challenges in the cardiovascular digital solutions market due to the sensitive nature of the health data being managed. For instance, wearable devices such as the Fitbit Charge or Apple Watch collect detailed cardiovascular data, including heart rate variability and ECG readings, which are transmitted to cloud servers for analysis. This data vulnerability is highlighted by the findings of The HIPAA Journal, which reported that in 2023, 725 data breaches were disclosed to the Office for Civil Rights (OCR), exposing or impermissibly disclosing over 133 million records. Consequently, hindering the market expansion.

• High Cost of Advanced Cardiovascular Digital Solutions

The high cost of advanced cardiovascular digital solutions poses a significant challenge for market adoption. For instance, high-end wearable devices with comprehensive cardiovascular monitoring capabilities and smart implants equipped with real-time health tracking features can be prohibitively expensive, often costing thousands of dollars. Such substantial price tag can limit accessibility, particularly for patients in low-income settings or those with inadequate insurance coverage. As a result, many individuals may not benefit from these cutting-edge technologies, which can impede widespread adoption and limit market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cardiovascular Digital Solutions Market Scope

The market is segmented on the basis of service type, components, deployment type, and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Service Type

• Unobtrusive Testing
• CVD Health Informatics
• Cardiac Rehab Programs

Components

• Devices
• Software

Deployment Type

• Cloud-Based/Web-Based
• On-Premise

End-Users

• Homecare Settings
• Ambulatory Care Centers
• Hospitals
• Clinics

Cardiovascular Digital Solutions Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, service type, components, deployment type, and end-users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the cardiovascular digital solutions market, driven by substantial healthcare spending and a strong focus on advanced medical technologies. The region's high adoption rate of healthcare information technology, coupled with well-established healthcare infrastructure, supports the widespread implementation of digital solutions in cardiovascular care. Additionally, the emphasis on improving patient outcomes and streamlining healthcare processes further propels market growth in North America

The Asia-Pacific region is projected to experience the fastest growth from 2024 to 2031, driven by significant improvements in healthcare infrastructure and the presence of leading healthcare IT vendors. Increased funding for research and development centers further supports this growth, enabling advancements in medical technologies and treatment solutions. Additionally, the region's expanding healthcare capabilities are attracting investments and fostering innovation, making it a key player in the global market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Cardiovascular Digital Solutions Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Cardiovascular Digital Solutions Market Leaders Operating in the Market Are:

• Zio by iRhythm Technologies, Inc. (U.S.)
• Apple Inc. (U.S.)
• GE HealthCare (U.S.)
• Baxter (U.S.)
• Cardiotrack (India)
• AliveCor, Inc. (U.S.)
• Verily (U.S.)
• HeartFlow, Inc. (U.S.)
• Bardy Diagnostics, Inc. (U.S.)
• BioTelemetry (U.S.)
• Nanowear Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Cardiac Insight Inc. (U.S.)
• EviCore Healthcare (U.S.)
• Wainscot Media (U.S.)
• Change Healthcare (U.S.)
• Medtronic (Ireland)

Latest Developments in Cardiovascular Digital Solutions Market

• 2022년 12월, Laza Medical은 3,600만 달러 규모의 Series a 자금 조달 라운드를 성공적으로 마감했다고 발표했습니다. 이 회사는 첨단 로봇 기술을 통합한 심장 개입을 위한 AI 기반 영상 솔루션 개발에 집중하고 있습니다. 자금 조달 라운드는 The Capital Partnership(TCP)이 주도했으며 GE HealthCare, PA MedTech VC 펀드, Unorthodox Ventures, Dara Holdings의 추가 투자가 있었습니다.
• 2022년 3월, Philips는 심초음파 기술을 강화하도록 설계된 ACC 2022 작업 공간 출시를 발표했습니다. 이 새로운 플랫폼을 통해 심장 전문의는 심초음파 카트 시스템 내외부에서 AI 기반 의료 영상 및 정량화 도구를 활용하여 생산성을 개선하고 일관성을 보장하며 진단 정확도를 높이는 것을 목표로 합니다.

SKU-39050